l General Information |
Product Name | Etofibrate |
General description | Etofibrate is a combination of clofibrate and niacin, used to treat hyperlipemia. |
Synonym | 2-[2-(4-chlorophenoxy)-2-methylpropanoyl]oxyethyl pyridine-3-carboxylate |
Purity | ≥99.0%(HPLC) | CAS Number | 31637-97-5 |
Formula | C18H18ClNO5 | Molecular Weight | 363.794 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Solid |
Solubility(25°C) | DMSO | ≥50mg/ml |
Water | Very slightly soluble |
l Biological Information |
Biochem/Physiol
Actions | Etofibrate is an orally-available combination of clofibrate and niacin ed together by an ester bond. In the body clofibrate and niacin separate, acting as a controlled-release formulation. |
Application | 1.Anticholesteremic Agents 2.Hypolipidemic Agents |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
